梧州招聘

Novartis Biologics is a dedicated biologics discovery and development organization. Over the past several years, Novartis has had the greatest number of new molecular entities approved by the FDA for clinical use in the US. Novartis is expanding its biologics capabilities to leverage its deep disease area expertise and innovative internal research, as well as discoveries made at leading academic institutions and biotechnology companies.
Novartis Biologics was established to accelerate the advancement of its rich biologics pipeline. It is dedicated to delivering new biologic therapies that improve the lives of patients. Novartis Biologics is entering a new phase of growth and we are seeking an innovative and energetic scientist and outstanding leader to direct and shape a newly formed antibody discovery group in Shanghai, China. Interested candidates will have substantial industry experience in antibody discovery and generation, focusing on both traditional hybridoma technique and high throughput in vitro B cell selection, antibody humanization, expression and characterization. Candidates should have a good understanding of the biological and pharmacological principles relevant to therapeutic antibody discovery and development.

Summary:
? Report to the Global Head of Protein Sciences and Design, Novartis Biologics.
? Establish a therapeutic antibody discovery powerhouse, including a state-of-the art and highly efficient hybridoma group and a high throughput in vitro B cell section group, in Shanghai, China.
? Responsible for the build up and management of a group of approximately 10 staffs, with potential growth, focusing on therapeutic antibody discovery, and researching and developing of novel therapeutic antibody platforms. This group interacts with discovery and development groups that are already established within Novartis.
? Contribute to strategic and scientific activities related to the discovery and design of therapeutic antibodies and novel technology platforms.

Responsibilities:
? Responsible for building up and managing the antibody discovery group in Shanghai, China. Manage lab resources and assess performance of associates.
? Work closely with colleagues of other functional areas at Novartis, will formulate, drive and deliver the strategy for therapeutic antibody discovery and generation in China for Novartis Biologics



? Identify, evaluate and manage appropriate outside research collaborations and alliances, in collaboration with PSD groups in Cambridge and Basel
? Work with IP to formulate an IP strategy for Protein Sciences and Design in China

Keyword: CNIBR, NIBR Shanghai? This role requires a PhD and/or MD in Biochemistry, Molecular Biology or Immunology and a minimum of 10 years of relevant experience in the biotechnology industry.
? Strong team-working focus and excellent communications and inter-personal skills.
? Strong proven track record in the discovery and generation of therapeutic antibodies. Solid knowledge and hands-on working experience in hybridoma generation and antibody humanization required.
? Management experience in a biotechnology or pharmaceutical company with demonstrated track-record of outstanding leadership.
? Industrial experience in taking antibody therapeutics from discovery stage to clinical development a strong plus.
? Fluent in both English and Mandarin a must.


To see a full job description for this position, please CLICK HERE

北京诺华制药有限公司开发、生产和销售治疗多种疾病的创新处方药，涵盖的疾病领域包括：心血管、内分泌、肿瘤、抗感染、风湿疼痛及骨质疏松、移植免疫、中枢神经以及眼科。北京诺华制药曾获得“***雇主”和“最负社会责任的企业”等殊荣。

“诺华”中文取意“承诺中华”，即承诺通过不断创新的产品和服务致力于提高中国人民的健康水平和生活质量。北京诺华制药成立于1987年，总部设在北京，隶属于瑞士诺华公司。

诺华公司致力于为患者及社会提供创新医药保健解决方案，以满足其日益变化的健康需求。2011年，集团持续经营业务实现净销售586亿美元。集团研发投入约为96亿美元（去除减值及摊销后为92亿美元）。诺华集团总部位于瑞士巴塞尔，业务遍及全球140多个国家和地区，拥有124,000位全职员工。诺华集团立足在中国的长期发展，重要战略投资包括位于上海的综合性生物医学研发中心，以及位于北京昌平的制剂生产工厂和江苏常熟的原料药生产工厂。如需更多信息，敬请登录公司网站http://www.novartis.com和http://www.novartis.com.cn。